This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

Costs In Context

PROLOGUE

Costs In Context

PROLOGUE: The issue of drug spending has climbed back to prominence on the national agenda in a remarkably short time. Spectacular innovations, international pricing controversies, the question of Medicare coverage, direct-to-consumer advertising, and rapid drug spending increases at a time when other health cost growth was in check have all contributed to the galloping escalation of public policy interest.

The learning curve for complex health system issues is always steep, but the rapid emergence of concern about drug spending puts policymakers and the public even further behind the curve than usual. Because so many are affected so deeply, the tendency . . . [Full Text of this Article]

                      What's this?